Hierarchical Commensurate and Power Prior Models for Adaptive Incorporation of Historical Information in Clinical Trials

被引:284
作者
Hobbs, Brian P. [1 ]
Carlin, Bradley P. [2 ]
Mandrekar, Sumithra J. [3 ]
Sargent, Daniel J. [3 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA
[2] Univ Minnesota, Div Biostat, Minneapolis, MN 55455 USA
[3] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA
关键词
Adaptive designs; Bayesian; Clinical trials; Colorectal cancer; Power priors; FLUOROURACIL; LEUCOVORIN; IRINOTECAN;
D O I
10.1111/j.1541-0420.2011.01564.x
中图分类号
Q [生物科学];
学科分类号
090105 [作物生产系统与生态工程];
摘要
Bayesian clinical trial designs offer the possibility of a substantially reduced sample size, increased statistical power, and reductions in cost and ethical hazard. However when prior and current information conflict, Bayesian methods can lead to higher than expected type I error, as well as the possibility of a costlier and lengthier trial. This motivates an investigation of the feasibility of hierarchical Bayesian methods for incorporating historical data that are adaptively robust to prior information that reveals itself to be inconsistent with the accumulating experimental data. In this article, we present several models that allow for the commensurability of the information in the historical and current data to determine how much historical information is used. A primary tool is elaborating the traditional power prior approach based upon a measure of commensurability for Gaussian data. We compare the frequentist performance of several methods using simulations, and close with an example of a colon cancer trial that illustrates a linear models extension of our adaptive borrowing approach. Our proposed methods produce more precise estimates of the model parameters, in particular, conferring statistical significance to the observed reduction in tumor size for the experimental regimen as compared to the control regimen.
引用
收藏
页码:1047 / 1056
页数:10
相关论文
共 16 条
[1]
Bayesian clinical trials [J].
Berry, DA .
NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (01) :27-36
[2]
A CASE FOR BAYESIANISM IN CLINICAL-TRIALS [J].
BERRY, DA .
STATISTICS IN MEDICINE, 1993, 12 (15-16) :1377-1393
[3]
Berry SM, 2010, CH CRC BIOSTAT SER, P1, DOI 10.1201/EBK1439825488
[4]
ON FOUNDATIONS OF STATISTICAL-INFERENCE [J].
BIRNBAUM, A .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1962, 57 (298) :269-&
[5]
The Relationship Between the Power Prior and Hierarchical Models [J].
Chen, Ming-Hui ;
Ibrahim, Joseph G. .
BAYESIAN ANALYSIS, 2006, 1 (03) :551-574
[6]
Using historical data for Bayesian sample size determination [J].
De Santis, Fulvio .
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY, 2007, 170 :95-113
[7]
Evaluating water quality using power priors to incorporate historical information [J].
Duan, YY ;
Ye, KY ;
Smith, EP .
ENVIRONMETRICS, 2006, 17 (01) :95-106
[8]
A Case for Robust Bayesian Priors with Applications to Clinical Trials [J].
Fuquene, Jairo A. ;
Cook, John D. ;
Pericchi, Luis R. .
BAYESIAN ANALYSIS, 2009, 4 (04) :817-845
[9]
A Randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer [J].
Goldberg, RM ;
Sargent, DJ ;
Morton, RF ;
Fuchs, CS ;
Ramanathan, RK ;
Williamson, SK ;
Findlay, BP ;
Pitot, HC ;
Alberts, SR .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (01) :23-30
[10]
Ibrahim JG, 2000, STAT SCI, V15, P46